Valganciclovir for the Prevention of Complications of Late Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation: A Randomized Controlled Trial

BACKGROUND: Optimal prevention of late cytomegalovirus (CMV) disease remains poorly defined. OBJECTIVE: To compare valganciclovir prophylaxis with PCR-guided preemptive therapy. DESIGN: Randomized, double-blind trial. Patients were randomized to valganciclovir or placebo. ClinicalTrials.gov registra...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ann Intern Med
Autores principales: Boeckh, Michael, Nichols, W. Garrett, Chemaly, Roy F., Papanicolaou, Genovefa A., Wingard, John R., Xie, Hu, Syrjala, Karen L., Flowers, Mary E.D., Stevens-Ayers, Terry, Jerome, Keith R., Leisenring, Wendy
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4465336/
https://ncbi.nlm.nih.gov/pubmed/25560711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7326/M13-2729
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares